Lifeward Ltd. (LFWD), a global innovator in medical technology for individuals with physical disabilities, has announced the pricing of a public offering.
The offering includes 4,000,000 ordinary shares and accompanying warrants to purchase the same number of shares, all priced at $0.65 per unit. Each warrant is immediately exercisable at $0.65 and will remain valid for five years from the issuance date.
The offering is expected to close around June 26, 2025, contingent on standard closing conditions.
Lifeward anticipates gross proceeds of approximately $2.6 million before fees and expenses. Should all warrants be exercised for cash, the company could receive an additional $2.6 million. Proceeds will support ongoing commercial activities, working capital, and general corporate needs.
LFWD currently trades at $0.5972 or 38.3249% lower on the NasdaqCM.
For comments and feedback: editorial@rttnews.com